If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
New Product Development » New Product Planning
Download FREE Excerpt
18 Info Graphics
17 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
The pressure is always on for pharmaceutical and biotech companies to produce effective new products and to minimize development costs. The New Product Planning (NPP) function is heavily involved in many of the activities that create a picture of how (and if) the new product will fit in the competitive landscape. With many millions hanging in the balance, it's important for NPP teams to get it right. One of the key factors that influence a NPP team's effectiveness is the resources an organization puts into its NPP effort.
Best Practices, LLC undertook this benchmarking study to investigate how leading companies are resourcing their NPP programs, both in terms of budget and FTEs. The study also looks at what are the most valuable activities that NPP teams perform. Leaders involved with New Product Planning process can use this study to compare their NPP resource levels with peer organizations.
For this research project, Best Practices, LLC engaged 19 leaders from 15 leading pharmaceutical, biotech, and life sciences companies.
Biopharmaceutical; Pharmaceutical; Medical Device; Biotech; Health Care; Clinical Research; Laboratories; Manufacturing; Consumer Products; Diagnostic
Alkermes; Zydus Cadila; GlaxoSmithKline ; Astellas; Roche; Novartis; Sanofi; Pfizer; Takeda Pharmaceuticals; Cytokinetics; Allergan; Medicago; Bayer; Galderma; Wockhardt